Latest Headlines

  1. Todos Medical Signs Binding Term Sheet With HWH World For Network Marketing Of Blood Tests For The Early Detection Of Breast Cancer
    9/13/2019

    Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced it has entered into a binding term sheet with HWH World Pte Ltd. (“HWH World”), a wholly-owned subsidiary of Singapore eDevelopment (SGX:40V) for the grant of exclusive marketing rights for Todos Medical’s TM-B1 and TM-B2 tests to HWH World’s network of members in Singapore, Malaysia, the Philippines, Vietnam, Thailand, Indonesia, South Korea, Hong Kong, China, the United States and Canada

  2. Quest Diagnostics And hc1 Collaborate To Optimize Enterprise-Wide Laboratory Testing For Health Systems
    9/13/2019

    Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™ powered by hc1®, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization

  3. High Performance Refractive Index Detector
    9/12/2019

    Testa Analytical Solutions e.K is now offering optimized versions of its proprietary Differential Refractive Index (DRI) Detector under OEM contract to enhance the performance of both HPLC and GPC/SEC systems

  4. Reading 2D-Barcoded Tubes Straight From The Freezer
    9/11/2019

    The Ziath range of single tube scanners, compact rack readers and large multi-rack readers are all capable of reading 2D-barcoded tubes straight from the freezer

  5. MOBILion Introduces Its First Ion Mobility Product In Partnership With Agilent To Provide Unprecedented Separation And Mass Spectrometry Capabilities
    9/10/2019

    MOBILion Systems, Inc. is partnering with Agilent Technologies Inc. to integrate its patented ion mobility separations technology, called Structures for Lossless Ion Manipulation (SLIM), with Agilent’s Q-TOF mass spectrometry platform as the company’s first commercial product offering

  6. Nano Discovery Inc. Launches A New Blood Test For Cattle Immune Health Testing
    9/9/2019

    Nano Discovery Inc. announced recently that it has launched a new blood test to the market for cattle immune health testing. Cattle owners and veterinary practitioners can order this test by submitting blood samples to Nano Discovery’s central laboratory, or conduct this test in their local farms and clinics by purchasing testing kits from the company

  7. Charles River Laboratories Announces Updates To Microbial Solutions Product Portfolio
    9/9/2019

    Charles River Laboratories International, Inc. recently announced the launch of two new products in its Microbial Solutions portfolio: an updated EndoScan-V software platform for endotoxin detection and measurement; and the introduction of the Celsis automated detection solution for rapid sterility to ensure continued product quality and contamination control for pharmaceutical manufacturing clients

  8. Ground-Breaking Trial Demonstrates Potential Of Blood Test Which Harnesses The Power Of The Immune System To Reduce Late Detection Of Lung Cancer
    9/9/2019

    Oncimmune Holdings plc (AIM: ONC.L), a leading global immunodiagnostics group, welcomes the presentation of data recently by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis

  9. ZRT Laboratory Receives NIH Grant Award To Help Understand ADHD
    9/9/2019

    ZRT Laboratory, a CLIA-certified diagnostic laboratory, announced today the receipt of a Phase I grant from the National Center for Complementary and Integrative Health under the auspices of the Small Business Innovation Research (SBIR) program of the National Institutes of Health

  10. Saladax Develops First-Ever Rapid Test For An Antipsychotic Drug Using A Single Drop Of Blood To Aid Psychiatrists In the Treatment Of Schizophrenia
    9/5/2019

    Saladax Biomedical recently announced that its MyCare Insite Clozapine Test is now CE marked for use on the MyCare Insite